![Laurie Doyle](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Laurie Doyle
Investor Relations Kontakt bei
GPC Biotech, Inc.
Profil
Ms. Laurie Doyle is a Director-Corporate Communications at GPC Biotech, Inc. and a Director-Corporate Communications at Transgene SA.
Ms. Doyle was previously employed as Senior Director-US Investor Relations by Agennix AG.
Aktive Positionen von Laurie Doyle
| Unternehmen | Position | Beginn |
|---|---|---|
GPC Biotech, Inc.
 GPC Biotech, Inc. Drugstore ChainsRetail Trade Develops anticancer drugs | Investor Relations Kontakt | - |
Ehemalige bekannte Positionen von Laurie Doyle
| Unternehmen | Position | Ende |
|---|---|---|
| TRANSGENE | Public Communications Contact | - |
| AGENNIX AG | Public Communications Contact | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
2
Beziehungen ersten Grades
3
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 3 |
|---|---|
Transgene SA
 Transgene SA BiotechnologyHealth Technology Designs and develops therapeutic vaccines and oncolytic viruses for the treatment of cancer | Health Technology |
GPC Biotech, Inc.
GPC Biotech, Inc. Drugstore ChainsRetail Trade Develops anticancer drugs | Retail Trade |
Agennix AG
 Agennix AG BiotechnologyHealth Technology Discovers, develops and commercializes new anti-cancer drugs | Health Technology |
